Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Announces its 9th Annual Microbiology Virtual Week Online Event, Scheduled on September 5-7, 2023


News provided by

Labroots

Aug 31, 2023, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Microbiology Week, September 5-7
Microbiology Week, September 5-7

The 3-day symposium spanning topics such as Immunology, Emerging and Re-Emerging Viruses, Microbes and Their Communities, and Infectious Disease, will explore the latest developments in Microbiology and Immunology

YORBA LINDA, Calif., Aug. 31, 2023 /PRNewswire-PRWeb/ -- Yorba Linda, CA (August 31, 2023) - Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is delighted to announce its annual Microbiology Virtual Week free online event. On September 5-7, 2023, research scholars, top scientists, healthcare professionals, microbiologists, infectious disease specialists, and clinicians will gather under a virtual roof to hear from well-renowned speakers discussing their recent advancements in the field.

The informative, educational 3-day agenda will include thought leaders from industry and academia institutions delivering dynamic presentations, including distinguished keynote deliveries and panel presentations you won't want to miss!

Keynote Speakers spanning the program at Microbiology Virtual Week 2023 include the following:

  •     Ivan Zanoni, PhD, Associate Professor of Pediatrics, Boston Children's Hospital Chair in the Field of Immunology, Harvard Medical School, Research Faculty, Division of Immunology, Division of Gastroenterology, Boston Children's, discussing: Interferons: Friends or Foes in Lung Virus Infections? With Live Q&A.
  • Nischay Mishra, PhD, Assistant Professor, Epidemiology, Center for Infection and Immunity, Columbia University, sharing insights on Pathogen Discovery and Diagnostic Tools for Pandemic Preparedness and Prevention, with Live Q&A.
  • Sean Conlan, PhD, Associate Investigator, Microbial Genomics Section, National Human Genome Research Institute, exploring Comparative Genomics of Two Common Skin Microbiome Members: CoNS Staphylococcus and Corynebacterium Tuberculostearicum, with Live Q&A.
  •  Melissa J. Caimano, PhD, Associate Professor, Departments of Medicine, Pediatrics, Molecular Biology and Biophysics, UConn Health, discussing c-di-GMP Signaling in Borrelia Burgdorferi: A Guiding Compass for Navigating the Enzootic Cycle, with Live Q&A.
  •  Gaya K. Amarasinghe, PhD, Alumni Endowed Professor of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, on the Role of LDL Related Receptor Proteins in Viral Infection, with Live Q&A.

Dr. Ivan Zanoni, Associate Professor of Pediatrics, Boston Children's Hospital Chair in the Field of Immunology, Harvard Medical School, Research Faculty, Division of Immunology, Division of Gastroenterology said, "The COVID-19 pandemic brought a terrible burden in terms of loss of lives. Nevertheless, the scientific community exploited the SARS-CoV-2 virus to better understanding the functioning of the immune system. In this lecture, I will focus on two aspects related to the immune response to SARS-CoV-2, and to lung virus infections: i) I will discuss how interferons (a group of cytokines able to "interfere" with virus replication) play both protective and detrimental roles in a mouse model of lung virus infection and in COVID-19 patients; ii) I will show how harnessing the physical properties of microbial components may lead to the development of more effective vaccines against SARS-CoV-2 and influenza A virus."

Dr. Nischay Mishra, Assistant Professor at The Center for Infection and Immunity (CII), Columbia University said, "Preparation for future pandemics start with timely pathogen discovery, rapid affordable diagnostics, efficient containment, and availability of such tools globally. The CII is committed to developing cutting-edge molecular and serological platforms, discovering pathogens, monitoring infectious diseases, studying zoonoses/reverse zoonoses events, responding to outbreaks and pandemics, and explaining role of microbes in acute and chronic illnesses. We have collaboration with scientists from 50+ countries, and we are building advanced research capacity worldwide. We have identified 2,000+ viruses, developed accurate microbial screening and diagnostic techniques, and obtained regulatory approvals."

"Over the past 50 years, Lyme disease has emerged as a global threat to public health," said Melissa Caimano, Associate Professor, Department of Medicine, UConn Health. "My work focuses on how Borrelia burgdorferi, the agent of Lyme disease, responds to signals encountered within its arthropod vector and mammalian host. LabRoots' platform will provide us with a framework for identifying novel strategies for interrupting the spirochete's enzootic cycle, thereby reducing the threat of disease for humans within endemic areas."

Dr. Gaya Amarasinghe, Alumni Endowed Professor of Pathology and Immunology at The Washington University School of Medicine said, "There's still a lot that we don't know about many pathogens and their interactions with the host during infection and particularly, the host responses after infection. These are critical for understanding threats as well as therapeutic opportunities. The significance of such approaches was further highlighted during the recent COVID 19 pandemic as well as outbreaks involving the Ebola virus and the Zika virus. Our goal is to define how key host-viral interactions contribute to hemorrhagic fever virus infections. Our studies will primarily focus on filoviruses and bunya viruses. These are known causative agents of recent outbreaks of viral hemorrhagic fever.

The scientific symposium explores additional topics such as the impact of the hypoxic gut microenvironment on host enteric pathogen interactions, bacterial chemotaxis in beneficial plant-microbe associations, innate immunity and microbiome of the human female reproductive tract, advancing RSV research: expanding therapeutic options with recombinant antibodies and antigens, implementing a real-time PCR-based method for sterility release testing of ATMPs via a panel presentation, machine learning insights into antimicrobial efficacy and resistance, utilizing molecular technologies to drive productivity in the microbiology lab, and so much more.

While connecting across all desktops and mobile devices, the online environment encompasses a lobby with leaderboard and gamification, an auditorium featuring live-streaming video webcasts offering live attendee chats during scheduled presentations, an interactive poster hall featuring a poster competition and live chat conversations), exhibit hall (interact with sponsors and view the latest array of products and technologies), and a networking lounge to connect with your colleagues. By participating in this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits.

To register for the event, click here. Participants can use the official hashtag #LRmicro to follow the conversation and connect with other members of the global Microbiology community. Follow @Microbiology_LR on Twitter and @Microbiology.LR on Facebook to connect with our specialist Microbiology Writers and stay up to date with the latest Trending News in Microbiology. And now, you can also join our Microbiology Interest Group on LinkedIn to connect with us, and the wider professional Microbiology community!

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected], www.labroots.com

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.